Pfizer and Mylan’s Magic Pill Merger 💊

Pfizer and Mylan’s Magic Pill Merger

Merger-mania continues, this time matching illness to cure. Huge pharmaceuticals giant Pfizer is going to open up its drug cabinet with Mylan, a smaller player. What’s that tucked in the back corner? Viagra? Investors are waiting for the stock popping effect to kick in!

The “big pharma” landscape looks pretty ugly. Frenzied mergers and acquisitions may have kept Wall Street busy, but it’s left many famous market picks like J&J and Bayer, looking somewhat makeshift. Given the multi-million-dollar business units sellotaped to the side of pharmaceuticals, hanging off the side after quick and dirty dealings,  investors have a job to do in judging pharma stocks.

And now Viagra’s getting involved. Pfizer, whose flagship magic pill has brought in riches, is giving its off-patent and generic medicines business the usual ‘big pharma” treatment. It’ll be split, spun, carved out, and merged, with Mylan, another pharma company, becoming an additional parent. The deal will be cashless, completed in stock-only, and the new CEO and man behind the little blue pills; Pfizer’s own, Michael Goattler.

Sometimes, the motivation behind a spin-off isn’t clear. On Pfizer’s side of the deal, we can hazard a guess. The Viagra effect on profit growth is wearing off for the firm; it’s now wanting to innovate more with newer lab creations. As for Mylan, the company complained for years that its stock was undervalued before sales of a critical drug flopped. The stock could do with some kind of lift. 

It’s working! Mylan just soared as Pfizer investors question the company’s decision to share those drugs. This saga isn’t over. Stay in the loop!

Share:
More Posts
Load More
Get your daily Invstr Crunch

Get the market news and updates you need, delivered to your inbox or available on our daily podcast.

Facebook Twitter Youtube Instagram Snapchat Tiktok
learn
products
plan
Who we are
blog

Risk Disclosure:

Invstr is not a bank and banking services are provided by Vast Bank, N.A.

Brokerage and Banking services are currently only available to U.S. residents.

Invstr app and web services are provided by Invstr Ltd. Advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC) details of which can be obtained here. Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value.

Investing involves risk and can lead to losses. Past performance does not guarantee future results.

Invstr app and web services are provided by Invstr Ltd. Invstr+ advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC). Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value. Vast Bank N.A. a nationally chartered bank and member of the FDIC, provides the banking products, including the products and services related to digital asset accounts. As with any asset, the value of Digital assets can go up or down and there can be a substantial risk that you lose money buying or holding digital assets. You should carefully consider whether trading or holding Digital assets is suitable for you in light of your financial condition. Your digital account does not support wallet to wallet transferring of your digital assets (i.e. cryptocurrencies) outside the platform. Any Digital Assets in your digital asset account are not insured by any government entities, including but not limited to FDIC or SIPC. The Invstr Visa® Debit Card is issued by Vast Bank, N.A. pursuant to a license from Visa U.S.A Inc and may be used everywhere Visa debit cards are accepted. Invstr Ltd, Invstr Financial LLC and Invstr Securities Ltd are subsidiaries of Marketspringpad Holdings (collectively “Invstr”) and Invstr is solely responsible for the application services and website content.

Watchlists provided when users first access the service are not a recommendation to invest. Instead they are provided to help users better navigate the service. Users are free to edit and create their own watchlists. From time to time, Invstr will suggest instruments solely based on an individual’s interest and the interest levels of the Invstr community. The statistical and portfolio builder models generated by Invstr do not reflect actual investment results and are not guarantees of future results. Comments provided by Invstr leaders, influencers or members of the Invstr Community are not recommendations and should not be construed as such. Invstr does not endorse the content or the positions posted by them. Their investment approach, and that of the models provided by Invstr, may be different from yours and may not be appropriate for you.